Lisa Otey
Obstetrics & Gynecology · Houston, TXNPI 1912093196
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,404 of the $5,221 with a category attached, or 65.2%. It is spread thinly across 36 manufacturers, the largest accounting for just 23.0%. Reporting peaked in 2022 at $2,914 and has fallen 71.1% since, to $842 in 2025.
Across 162 payments — averaging $32.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scynexis, Inc.$1K
- Acessa Health Inc.$1K
- AbbVie$680
- Mayne Pharma Commercial LLC$280
- Myovant Sciences Inc.$256
- Sumitomo Pharma America, Inc.$201
- plus $2K from 30 others
What the payments were for
- Consulting fees$1,00019%
- Travel & lodging$81716%
- Food & beverage$3,40465%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scynexis, Inc. | 5 | $1,202 |
| Acessa Health Inc. | 6 | $1,069 |
| AbbVie | 46 | $680 |
| Mayne Pharma Commercial LLC | 17 | $280 |
| Myovant Sciences Inc. | 11 | $256 |
| Sumitomo Pharma America, Inc. | 8 | $201 |
| Amgen | 8 | $197 |
| Agiliti Surgical, Inc. | 1 | $141 |
| Exeltis, USA Inc. | 6 | $116 |
| Avion Pharmaceuticals | 6 | $92 |
| Astellas Pharma US Inc | 3 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $76 |
| Pfizer | 4 | $73 |
| Gilead | 2 | $69 |
| Bayer | 3 | $60 |
| Millicent US Inc | 2 | $45 |
| Organon | 2 | $45 |
| AstraZeneca | 2 | $43 |
| Abbott | 2 | $43 |
| Myriad Women's Health, Inc. | 1 | $43 |
| Merck | 3 | $40 |
| Hologic Sales And Service, LLC | 2 | $36 |
| Johnson & Johnson | 1 | $35 |
| Agile Therapeutics, Inc. | 2 | $35 |
| Aspira Women's Health Inc | 1 | $34 |
| Exact Sciences | 2 | $34 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $33 |
| Corcept Therapeutics | 2 | $30 |
| Mylan Pharmaceuticals Inc. | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Lupin Inc. | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Shield Therapeutics Inc | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Cranial Technologies, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACESSA PROVU SYSTEM$1,043
- Boston Scientific AcuPulse DUO CO2 Laser$141
- Boston Scientific UltraPulse DUO CO2 Laser$141
- Omniguide Intelliguide Flexible Fiber CO2 Laser$141
- Blue Light Lasers$141
- GE Healthcare bk3000/bk5000 Ultrasound$141
- EVENITY$124
How this compares
$5,221 in reported general payments places this provider in the 85th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluconazole | 18 | $72 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Houston
- George KuhnHouston$244K
- Daisy AyimHouston$188K
- Shannon WestinHouston$176K
- Asha BhalwalHouston$151K
- Nicole TranHouston$133K
- Sandra HurtadoHouston$123K
- Alvaro MontealegreHouston$92K
- Patti RossHouston$72K
- Damla KarsanHouston$58K
- Christopher JayneHouston$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.